It has been shown that RhoA plays some role in cardio-protective signaling, especially adaptive hypertrophy, but the detrimental effects of RhoA activation in cardiomyocytes predominate and it is associated with pathological hypertrophy and heart failure. This evidence concerns the gene RHOA and heart failure.